Lipoedema is a chronic progressive disorder of adipose tissue leading to an enlargement of lower extremities. It is considered to be rare; however, the prevalence of the disease is underestimated because it is commonly misdiagnosed as obesity or lymphedema and the general awareness is poor. The etiology of the disorder is considered to be multifarious, including genetic inheritance, hormonal imbalance and microcirculation alterations. Diagnosis is mainly based on medical history and physical examination. Management of lipoedema is focused on reducing the symptoms, improving the quality of life and preventing further progression of the disease. The aim of this paper is to raise the awareness of the disease and provide appropriate clinical guidance for the assessment of lipoedema. We searched through the PubMed/MEDLINE database and took into consideration all of the results available as of 6September, 2020 and outlined the current evidence regarding lipoedema epidemiology, etiology, clinical presentation, differential diagnosis, and management. Better understanding of lipoedema is crucial for establishing an early diagnosis and a proper treatment, which in turn will reduce the psychological and physical implications associated with the disease.
Background: Large language models (LLMs) are increasingly being evaluated for clinically relevant diagnostic tasks, yet their performance may vary across languages. We aimed to determine whether input language influences LLM diagnostic reasoning in vignette-based clinical tasks and to inform multilingual predeployment evaluation for non-English healthcare systems. Methods: In this translation-controlled in silico study, 30 real-patient’s clinical vignettes were presented in paired English- and Polish-language conditions using back-translated prompts and cases. Six LLMs were evaluated with a structured reflection framework adapted from medical education. The study included 720 rater-level evaluations and 360 unique model–language–vignette responses. Responses were independently scored by 2 physician raters, with major discrepancies adjudicated by a third physician. The primary outcome was total rubric score. Secondary outcomes included differential diagnosis quality, justification, appropriateness of additional examinations, final diagnosis, and triage accuracy. Exploratory analyses assessed the number and cost of recommended examinations. Results: The effect of language differed significantly by model. Qwen2.5, Llama3.3, Meditron3, and OpenBioLLM performed significantly better in English, with the largest gap observed for Qwen2.5. GPT-5 and Bielik showed no statistically detectable English-Polish difference in overall score in this sample. Language-related differences were most evident in differential diagnosis quality, justification, and examination planning rather than in final diagnosis alone. Exploratory economic analyses suggested model- and language-dependent differences in testing burden, with broader suggested workups generally associated with higher diagnostic costs. Language robustness was not a consistent property of clinically evaluated LLMs. Performance differences were concentrated in reasoning and workup domains that are safety-relevant if these systems are used clinically. Conclusions: Multilingual clinical performance of LLMs is strongly model dependent. Language-specific evaluation should be considered before deployment in non-English healthcare systems.
7 October 2020 in Journal of Education, Health and Sport
Introduction: Acromegaly is a chronic disease resulting from increased secretion of growth hormone. The main reason of elevated GH concentration is pituitary adenoma that originates from somatotropic cells. As a consequence, several changes in the organism appear such as progressive deformation of the skeleton with enlargement of the skull, hands and feet, growth of soft tissues, bones and internal organs as well as many other systemic complications which are responsible for increased mortality in untreated patients. Case report: A 60-year-old patient was diagnosed with acromegaly due to the pituitary macroadenoma and associated hypopituitarism in the thyroid and gonadotropic axis 4 years ago. The disease was suspected in April 2016 by a rheumatologist, and then confirmed on the basis of hormonal tests in the Endocrinology Clinic (IGF1 - 754.7 ng/ml, N: 77-224; GH - 2.51 ng/ml, no inhibition in OGTT). The imaging examination revealed a pituitary macroadenoma with dimensions of 17x15x19 mm. The medical history revealed the characteristic symptoms of acromegaly like enlargement and deformation of the fingers, enlarged nose, excessive sweating and headaches for the last 12 years. There have been several studies investigating the complications of acromegaly that found abnormalities in the cardiovascular system, metabolic disorders (dyslipidemia, abnormal fasting glycaemia), arthropathies, sigmoid polyps and nodular goiter. Due to the patient's lack of consent to the surgical intervention, treatment with a somatostatin analogue was introduced. During 2-year therapy, the normalization of IGF-1 concentration was not achieved. In October 2018 patient completely abandoned therapy with somatostatin analogue. In 2019 the lack of control of acromegaly was confirmed. During hospitalization in 2020 the uncontrolled acromegaly was stated once again. The patient still does not consent to the surgical procedure to remove pituitary macroadenoma, however, he agreed for systematic re-treatment with a somatostatin analogue. Conclusions: Isolated pharmacological treatment doesn’t always allow for sufficient control of an illness. Effective treatment of acromegaly should consist of surgery as well as conservative treatment. The introductinon of both 2nd generation analogues and GH receptor antagonists in therapeutic programs makes effective pharmacological treatment possible.
1 September 2020 in Journal of Education, Health and Sport
Introduction: An aneurysm of the abdominal aorta (AAA) is a local aortic dilatation, most often below the departure of renal arteries. It is becoming an increasingly common health issue amongst people over 65 years of age and poses a direct threat to life. However, early diagnosis, proper treatment and postoperative care significantly increase the chances for long-term survival. The currently available methods of treatment of an abdominal aortic aneurysm are surgical and include classical or endovascular approach. The classical method is an open operation consisting of the replacement of a changed section the aorta for a vascular prosthesis. Endovascular surgery protects the aneurysm from rupture by placing the peripheral vascular stent-graft access to the light of the aneurysm. Aim and method: Comparison of two methods of treatment of abdominal aortic aneurysm: classical and endovascular in patients. We searched through the PubMed database and took into consideration all of the results available as of September 2020 and outlined the current evidence regarding AAA etiology, symptoms, clinical course, diagnosis and treatment. Results and conclusion: Both classical and endovascular methods have similar long-term survival rates. More early complications can be observed in the classical method and late complications in the endovascular one. The choice which method the patient should be treated with should depend on the operators' experience with the method and their individual approach to the patient.